跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Medtazime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Medtazime
Approved
STANDARD
Medtazime
Ananta Medicare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
895d065fd56e53d0
Company
Ananta Medicare Limited
Type
Standard
Approval Details
Approval Id
895d065fd56e53d0
Drug Approval Philippines Name
Medtazime
Product Name
Medtazime
Registration Number
DRP-14218
Brand Name
Medtazime
Generic Name
Ceftazidime (As Sodium)
Dosage Form
Powder For Injection (Im/Iv)
Dosage Strength
1 g
Manufacturer
Ananta Medicare Limited
Importer
Medinova Pharmaceutical, Inc.
Distributor
Medinova Pharmaceutical, Inc.
Issuance Date
28 July 2023
Expiry Date
28 July 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
895d065fd56e53d0
Type
Standard
Back to Philippines FDA Approvals